tiprankstipranks

Cipher Pharmaceuticals price target raised to C$19 from C$17 at Stifel

Stifel raised the firm’s price target on Cipher Pharmaceuticals (CPHRF) to C$19 from C$17 and keeps a Buy rating on the shares.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1